Last reviewed 2026-05-27 · How we verify

Distal Water

Qassim University · Phase 1 active Small molecule ✓ Verified May 2026 Quality 0/100

Distal Water is a Small molecule drug developed by Qassim University. It is currently in Phase 1 development. Also known as: Deionized water.

Distal Water is a small molecule modality. It has been studied in various clinical trials for conditions such as periodontal diseases, spinal cord injuries, and idiopathic intracranial hypertension, among others.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Distal Water
Also known as	Deionized water
Sponsor	Qassim University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Distal Water CI brief — competitive landscape report
Distal Water updates RSS · CI watch RSS
Qassim University portfolio CI

Frequently asked questions about Distal Water

What is Distal Water?

Distal Water is a Small molecule drug developed by Qassim University.

Who makes Distal Water?

Distal Water is developed by Qassim University (see full Qassim University pipeline at /company/qassim-university).

Is Distal Water also known as anything else?

Distal Water is also known as Deionized water.

What development phase is Distal Water in?

Distal Water is in Phase 1.

Manufacturer: Qassim University — full pipeline
Also known as: Deionized water

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing